ADGM

Peers: BSX MDT ABT ICCM ATRC STXS AMIX NUWE NSPR CVRX

Index	-
Market Cap	2.36M
Enterprise Value	20.62M
Income	-27.14M
Sales	0.00M
Book/sh	-0.02
Cash/sh	0.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	41
IPO	Feb 26, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	0.30
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.15
Current Ratio	1.41
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-1.44
EPS next Y	-1.16
EPS next Q	-0.25
EPS this Y	27.81%
EPS next Y	-6.42%
EPS next 5Y	4.30%
EPS past 3/5Y	63.65% -364.47%
Sales past 3/5Y	- -
EPS Y/Y TTM	70.33%
Sales Y/Y TTM	-100.00%
EPS Q/Q	13.45%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-11.11% -

Insider Own	1.22%
Insider Trans	0.00%
Inst Own	54.93%
Inst Trans	-2.42%
ROA	-77.80%
ROE	-657.76%
ROIC	-107.02%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-26.26%
SMA50	-73.12%
SMA200	-88.62%
Trades

Shs Outstand	27.44M
Shs Float	27.10M
Short Float	0.49%
Short Ratio	0.01
Short Interest	0.13M
52W High	1.69 -94.91%
52W Low	0.08 3.61%
Volatility	20.31% 16.77%
ATR (14)	0.03
RSI (14)	26.29
Beta	-0.00
Rel Volume	0.00
Avg Volume	9.54M
Volume	0

Perf Week	-22.38%
Perf Month	-43.79%
Perf Quarter	-77.27%
Perf Half Y	-90.45%
Perf YTD	-91.73%
Perf Year	-92.77%
Perf 3Y	-99.21%
Perf 5Y	-99.14%
Perf 10Y	-
Recom	1.00
Target Price	3.33
Prev Close	0.09
Price	0.09
Change %	0.00%

Consensus

Strong Buy

Avg. Price Target

$3.33

Implied Upside

+3,772.1%

Analysts2incl. previous ratings

Rating Distribution2 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Apr 14, 2026	Initiated	PPiper Sandler	Overweight	$3	+3,388.4%
Dec 02, 2025	Initiated	LLake Street	Buy	$4	+4,551.2%

Sep-23-26 09:47AM	Adagio Medical Initiates Strategic Review and Workforce Reduction While Advancing vCLAS PMA (InvestorsHub) -53.04%
08:00AM	Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value (Business Wire)
Sep-16-26 08:00AM	Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS Ultra System for Ventricular Tachycardia at Banner - University Medical Center Phoenix (Business Wire) +7.99%
Sep-08-26 06:30AM	Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors (Business Wire) +7.71%
Aug-11-26 08:30AM	Adagio Medical Reports Second Quarter 2026 Results (Business Wire)
08:30AM	Loading…
Aug-03-26 08:30AM	Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System (Business Wire) +21.60%
May-21-26 08:00AM	Adagio Medical Submits Premarket Approval Application to FDA for vCLAS Ventricular Ablation System for the Treatment of Ventricular Tachycardia (Business Wire)
May-12-26 08:05AM	Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress (Business Wire)
Apr-29-26 08:00AM	Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference (Business Wire)
Apr-26-26 09:32AM	Adagio Medical Announces Positive Pivotal Results for vCLAS Ventricular Ablation System (Business Wire)
Apr-16-26 08:00AM	Adagio Medicals ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference (Business Wire)
Apr-06-26 08:00AM	Adagio Medical to Participate in the 25th Annual Needham Virtual Conference (Business Wire)
Apr-01-26 08:00AM	Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026 (Business Wire)
Mar-27-26 08:00AM	Adagio Medical Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Mar-24-26 08:00AM	Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter (Business Wire) +11.50%
08:00AM	Loading…
Mar-19-26 08:00AM	Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS System, Including Patients with Premature Ventricular Contractions (PVC) (Business Wire)
Mar-11-26 08:00AM	Adagio Medical to Participate in the 38th Annual Roth Conference (Business Wire)
Feb-24-26 01:11PM	Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study (Insider Monkey)
Feb-20-26 08:00AM	Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference (Business Wire)
Feb-04-26 08:00AM	New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia (Business Wire)
Feb-02-26 08:05AM	Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Dec-22-25 08:00AM	Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness (Business Wire) +5.83%
Dec-11-25 08:00AM	Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors (Business Wire)
Nov-12-25 04:05PM	Adagio Medical Reports Third Quarter 2025 Results (Business Wire)
Oct-20-25 08:00AM	Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia (Business Wire) +5.45%
Oct-15-25 08:00AM	Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities (Business Wire) -19.88%
Oct-10-25 03:40PM	Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium (Business Wire) -13.93%
Oct-01-25 08:00AM	Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia (Business Wire)
Sep-18-25 08:00AM	Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium (Business Wire) +11.66%
Sep-08-25 08:00AM	Adagio Medical Expands Chief Business Officer Deborah Kasters Role to Include Chief Financial Officer Responsibilities (Business Wire) -12.03%
04:30PM	Loading…
Aug-13-25 04:30PM	Adagio Medical Reports Second Quarter 2025 Results (Business Wire)
May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kaster Deborah	Chief Financial Officer	Dec 16 '25	Buy	1.20	15,000	17,973	15,000	Dec 18 06:00 AM
Usen Todd	Chief Executive Officer	Dec 12 '25	Buy	1.09	207,315	225,973	207,315	Dec 15 09:24 PM

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

CEO & DirectorMr. Todd Usen

CFO & Chief Business OfficerMs. Deborah Kaster

Senior Vice President of Manufacturing & OperationsMr. Antwan Gipson M.B.A.

Chief Technical OfficerDr. Alex Babkin Ph.D.

Chief Compliance OfficerMr. Nabil Jubran

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Adagio Medical Holdings Inc

Upgrade your Finviz experience